QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
Free Trial
ASX:1AD

AdAlta (1AD) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free 1AD Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
135,957 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
1AD stock logo

About AdAlta Stock (ASX:1AD)

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics by its i-body platform in Australia. Its lead product is AD-214, an antibody therapeutic, which is in Phase I clinical trial for the treatment of fibrotic diseases, including idiopathic pulmonary fibrosis and interstitial lung disease, kidney fibrosis, eye fibrosis, and various cancers. AdAlta Limited has collaborative partnerships with GE Healthcare to develop i-body enabled granzyme B PET imaging agents for use in immuno-oncology; and Carina Biotech to develop CAR-T cell products against various solid tumor antigens. The company was incorporated in 2006 and is based in Bundoora, Australia.

1AD Stock News Headlines

April 8, 2024 | msn.com
Long Shortz with AdAlta: Strengthening bonds in the fight against cancer
April 7, 2024 | msn.com
AdAlta and SYNthesis BioVentures collaborate on advanced cell-based cancer immunotherapy
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
March 8, 2024 | finance.yahoo.com
AdAlta delivers positive Phase I Extension Study results for AD-214
March 8, 2024 | msn.com
ScoPo’s (actually Wilkie’s) Powerplays: Health stocks rise as AdAlta soars 17% on trial results
February 15, 2024 | bbc.com
Leeds - Weather warnings issued
February 11, 2024 | msn.com
Countdown on to AdAlta trial results as biotech advances partner discussions
February 4, 2024 | finance.yahoo.com
AdAlta Insiders Placed Bullish Bets Worth AU$850.2k
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
January 22, 2024 | msn.com
AdAlta advancing partnering programs as AD-214 participants receive final dose
January 9, 2024 | es.investing.com
Adalta Ltd (1AD)
January 4, 2024 | msn.com
What’s in store for 2024: AdAlta
December 28, 2023 | msn.com
Money Talks: Keep an eye on these tasty precious metal and biotech plays in 2024
December 19, 2023 | msn.com
Long Shortz with AdAlta: How the company has potentially broken the malaria life cycle
December 18, 2023 | msn.com
‘World first’: AdAlta’s i-body platform a breakthrough for malaria treatment
December 13, 2023 | msn.com
AdAlta on track for trial readout in Q1 2024 after $1.65m cap raise
November 30, 2023 | msn.com
‘Best place we’ve ever been’: AdAlta looks to monetise lead asset in 2024
November 20, 2023 | msn.com
ASX Health Stocks: Painchek’s Europe patent accepted; and HeraMed signs deal with Telstra Health
November 20, 2023 | msn.com
AdAlta’s latest results bolster safety profile and dose selection for primary asset, enhancing partnering, reducing Phase 2 trial risks
November 18, 2023 | proactiveinvestors.com.au
AdAlta raises $1.65 million in oversubscribed placement to support clinical study and partner discussions
November 15, 2023 | finance.yahoo.com
It's Probably Less Likely That AdAlta Limited's (ASX:1AD) CEO Will See A Huge Pay Rise This Year
November 7, 2023 | proactiveinvestors.com.au
AdAlta closes oversubscribed $1.65 million raise
October 22, 2023 | proactiveinvestors.com.au
AdAlta making material progress on partnering talks
October 19, 2023 | au.investing.com
AdAlta to present lead product AD-214 at MPGPCR 2023 pharmacology conference
October 17, 2023 | proactiveinvestors.com.au
AdAlta receives $2.3 million FY23 R&D refund; extends loan repayment terms
September 26, 2023 | finance.yahoo.com
AdAlta says new AD-214 dosing models enhance partnering potential
September 24, 2023 | proactiveinvestors.com.au
AdAlta clinical dose simulations of AD-214 support target intravenous dose regime
See More Headlines
Receive 1AD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AdAlta and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:1AD
CUSIP
N/A
CIK
N/A
Web
www.adalta.com.au
Phone
61 3 9479 5159
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-5,040,000.00
Net Margins
-144.13%
Pretax Margin
N/A
Return on Equity
-196.58%
Return on Assets
-48.37%

Debt

Debt-to-Equity Ratio
82.91
Current Ratio
1.83
Quick Ratio
2.84

Sales & Book Value

Annual Sales
$3.50 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
1.94
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
525,810,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
0.67
10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Timothy Charles Oldham B.Sc.
    BSc(Hons), L.L.B., LLB(Hons), Ph.D., CEO, MD & Director
  • Mr. Angus Tester Ph.D.
    Senior Director of Operations
  • Ms. Janette Dixon
    Head of Business Development
  • Mr. Cameron Jones C.A.
    Company Secretary

Key Competitors

View All Competitors

Insiders


1AD Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of AdAlta own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AdAlta investors own include Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), iRhythm Technologies (IRTC), FBR (FBR), Embark Early Education (EVO), Dacian Gold (DCN), Constellation Technologies (CT1), Afterpay (APT).

This page (ASX:1AD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative